|

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

RECRUITINGSponsored by Abramson Cancer Center at Penn Medicine
Actively Recruiting
SponsorAbramson Cancer Center at Penn Medicine
Started2024-07-01
Est. completion2027-10
Eligibility
Age25 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

The overall goal of the Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer (PROMISE) study is to better understand how women may incorporate both polygenic risk score (PRS) and novel early detection strategies in their decisions regarding cancer screening and risk reducing surgery. This study will conduct qualitative interviews to better understand women's attitudes regarding polygenic risk score (PRS) and early detection assays.

Eligibility

Age: 25 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female, age 25 or older (given that women under this age are not generally recommended to receive BRCA1/2 genetic testing)
* Completed full sequence or targeted genetic testing with a clinically confirmed BRCA1 or BRCA2 deleterious mutation identified.
* English-fluent; the surveys and interviews were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.

Exclusion Criteria:

* Previous receipt of any prophylactic oophorectomy
* Personal history of ovarian cancer
* Major psychiatric illness or cognitive impairment that in the judgment of the study investigators would preclude study participation.
* Any patients who are unable to comply with the study procedures as determined by the study investigators or study staff.

Conditions3

BRCA MutationCancerOvarian Cancer

Locations1 site

Abramson Cancer Center
Jamie Brower, MS215-662-7245jabrower@pennmedicine.upenn.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.